Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines
Journal of Neuro-Oncology, 05/08/2012Beier D et al.
The data suggest the effectiveness of temozolomide (TMZ) in O6–methyl–guanidine–methyl–transferase (MGMT)–negative cancer stem cell (CSC) lines and support the concept of TMZ rechallenge. The 7 days on/7 days off scheme consistently showed the best activity of all schedules in TMZ–resistant CSC lines.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.